R. David Kelly's most recent trade in Acadia Healthcare Company Inc was a trade of 7,032 Common Stock done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Healthcare Company Inc | R. David Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 7,032 | 15,104 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | R. David Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 4,923 | 20,027 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | R. David Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 2,414 | 8,072 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | R. David Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,229 | 4,307 (0%) | 0% | 0 | Common Stock | |
| Acadia Healthcare Company Inc | R. David Kelly | Director | Grant, award, or other acquisition of securities at price $ 71.78 per share. | 18 May 2023 | 1,351 | 5,658 (0%) | 0% | 71.8 | 96,975 | Common Stock |
| Acadia Healthcare Company Inc | R. David Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 2,078 | 2,078 (0%) | 0% | 0 | Common Stock |